PL4073051T3 - Sposób i związek pośredni do wytwarzania oksetan-2-ylometanoaminy - Google Patents
Sposób i związek pośredni do wytwarzania oksetan-2-ylometanoaminyInfo
- Publication number
- PL4073051T3 PL4073051T3 PL20829133.6T PL20829133T PL4073051T3 PL 4073051 T3 PL4073051 T3 PL 4073051T3 PL 20829133 T PL20829133 T PL 20829133T PL 4073051 T3 PL4073051 T3 PL 4073051T3
- Authority
- PL
- Poland
- Prior art keywords
- ylmethanamine
- oxetan
- preparation
- Prior art date
Links
- QDEFNAHLCTUWAH-UHFFFAOYSA-N oxetan-2-ylmethanamine Chemical compound NCC1CCO1 QDEFNAHLCTUWAH-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D305/06—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962946146P | 2019-12-10 | 2019-12-10 | |
| PCT/US2020/063546 WO2021118906A1 (en) | 2019-12-10 | 2020-12-07 | Process and intermediate for the preparation of oxetan-2-ylmethanamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4073051T3 true PL4073051T3 (pl) | 2024-05-20 |
Family
ID=74003942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20829133.6T PL4073051T3 (pl) | 2019-12-10 | 2020-12-07 | Sposób i związek pośredni do wytwarzania oksetan-2-ylometanoaminy |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20230013840A1 (pl) |
| EP (1) | EP4073051B1 (pl) |
| JP (1) | JP7292517B2 (pl) |
| KR (1) | KR102635237B1 (pl) |
| CN (1) | CN114728923B (pl) |
| AU (1) | AU2020401539B2 (pl) |
| CA (1) | CA3160419A1 (pl) |
| CL (1) | CL2022001511A1 (pl) |
| CO (1) | CO2022008127A2 (pl) |
| DK (1) | DK4073051T3 (pl) |
| EC (1) | ECSP22046595A (pl) |
| ES (1) | ES2975599T3 (pl) |
| FI (1) | FI4073051T3 (pl) |
| HR (1) | HRP20240343T1 (pl) |
| HU (1) | HUE067201T2 (pl) |
| IL (1) | IL292707B2 (pl) |
| LT (1) | LT4073051T (pl) |
| MA (1) | MA58104B1 (pl) |
| MD (1) | MD4073051T2 (pl) |
| MX (1) | MX2022006984A (pl) |
| PE (1) | PE20230183A1 (pl) |
| PH (1) | PH12022551403A1 (pl) |
| PL (1) | PL4073051T3 (pl) |
| PT (1) | PT4073051T (pl) |
| RS (1) | RS65238B1 (pl) |
| SI (1) | SI4073051T1 (pl) |
| UA (1) | UA127884C2 (pl) |
| WO (1) | WO2021118906A1 (pl) |
| ZA (1) | ZA202205170B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116217522B (zh) * | 2023-02-22 | 2025-06-24 | 广东莱佛士制药技术有限公司 | Glp-1受体激动剂关键中间体的手性纯化方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208140B2 (en) * | 2003-02-19 | 2007-04-24 | Schering Aktiengesellschaft | Trimeric macrocyclic substituted benzene derivatives |
| US9556163B2 (en) * | 2011-05-06 | 2017-01-31 | Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag | Process for the preparation of a rivaroxaban and intermediates formed in said process |
| US9376409B2 (en) * | 2012-05-09 | 2016-06-28 | Boehringer Ingelheim International Gmbh | Methods for making oxetan-3-ylmethanamines |
| MY195385A (en) * | 2016-12-16 | 2023-01-18 | Pfizer | Glp-1 Receptor Agonists And Uses Thereof |
| CN109265389B (zh) * | 2018-08-31 | 2020-08-18 | 南京富润凯德生物医药有限公司 | 2-(氨基甲基)-1-氧杂-7-氮杂螺[3.5]壬烷衍生物、中间体及其制备方法 |
-
2020
- 2020-12-07 PE PE2022001046A patent/PE20230183A1/es unknown
- 2020-12-07 PT PT208291336T patent/PT4073051T/pt unknown
- 2020-12-07 WO PCT/US2020/063546 patent/WO2021118906A1/en active Application Filing
- 2020-12-07 CN CN202080082957.9A patent/CN114728923B/zh active Active
- 2020-12-07 DK DK20829133.6T patent/DK4073051T3/da active
- 2020-12-07 MA MA58104A patent/MA58104B1/fr unknown
- 2020-12-07 HR HRP20240343TT patent/HRP20240343T1/hr unknown
- 2020-12-07 SI SI202030381T patent/SI4073051T1/sl unknown
- 2020-12-07 US US17/779,447 patent/US20230013840A1/en active Pending
- 2020-12-07 IL IL292707A patent/IL292707B2/en unknown
- 2020-12-07 MD MDE20221148T patent/MD4073051T2/ro unknown
- 2020-12-07 FI FIEP20829133.6T patent/FI4073051T3/fi active
- 2020-12-07 HU HUE20829133A patent/HUE067201T2/hu unknown
- 2020-12-07 EP EP20829133.6A patent/EP4073051B1/en active Active
- 2020-12-07 LT LTEPPCT/US2020/063546T patent/LT4073051T/lt unknown
- 2020-12-07 PL PL20829133.6T patent/PL4073051T3/pl unknown
- 2020-12-07 MX MX2022006984A patent/MX2022006984A/es unknown
- 2020-12-07 ES ES20829133T patent/ES2975599T3/es active Active
- 2020-12-07 AU AU2020401539A patent/AU2020401539B2/en active Active
- 2020-12-07 RS RS20240243A patent/RS65238B1/sr unknown
- 2020-12-07 CA CA3160419A patent/CA3160419A1/en active Pending
- 2020-12-07 PH PH1/2022/551403A patent/PH12022551403A1/en unknown
- 2020-12-07 JP JP2022534655A patent/JP7292517B2/ja active Active
- 2020-12-07 UA UAA202201389A patent/UA127884C2/uk unknown
- 2020-12-07 KR KR1020227018626A patent/KR102635237B1/ko active Active
-
2022
- 2022-05-10 ZA ZA2022/05170A patent/ZA202205170B/en unknown
- 2022-06-08 CO CONC2022/0008127A patent/CO2022008127A2/es unknown
- 2022-06-08 CL CL2022001511A patent/CL2022001511A1/es unknown
- 2022-06-10 EC ECSENADI202246595A patent/ECSP22046595A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276917A (en) | A process for the preparation of alubixivet | |
| GB2593352B (en) | Process for the preparation of 3alpha-hydroxy-5alpha-pregnan-20-one (brexanolone) | |
| ZA202101214B (en) | Process and intermediates for the preparation of bilastine | |
| IL290185A (en) | Crystalline forms of risdiplam and their preparation process | |
| ZA202003590B (en) | Process for the preparation of opicapone and intermediates thereof | |
| IL289453A (en) | A process for the preparation of ridinilazole and crystalline forms thereof | |
| HUE062956T2 (hu) | Eljárások niraparib és köztitermékei elõállítására | |
| EP3717456A4 (en) | PROCESS FOR PREPARING ROXADUSTAT AND ITS INTERMEDIARIES | |
| IL289904A (en) | A process for preparing biphenylamines | |
| PL3765440T3 (pl) | Sposób wytwarzania n-alkilonitratoetylonitroamin | |
| IL281254A (en) | A process for the preparation of lanbatinib | |
| IL272837A (en) | A process for preparing tubolysins and their intermediates | |
| GB201915447D0 (en) | Polymorphs of avapritinib and methods of preparing the polymorphs | |
| HUE058259T2 (hu) | Eljárás lubiproszton és annak intermedierei elkészítésére | |
| PL3737685T3 (pl) | Sposób wytwarzania kryzaborolu i jego związków pośrednich | |
| PL4073051T3 (pl) | Sposób i związek pośredni do wytwarzania oksetan-2-ylometanoaminy | |
| PL3599256T3 (pl) | Sposób wytwarzania poliorganosiloksanów | |
| ZA202107053B (en) | Novel process for the preparation of filgotinib and intermediates thereof | |
| IL280312A (en) | Process for preparing bromodomain inhibitors | |
| HUP1800278A2 (en) | Process for the preparation of boc-linagliptin | |
| PL3969459T3 (pl) | Sposób i produkty pośrednie do otrzymywania eldekalcytolu | |
| EP3941917A4 (en) | IMPROVED PROCESS FOR THE MANUFACTURE OF ELIGLUSTAT AND ITS INTERMEDIATE | |
| HK40083307A (en) | Process and intermediates for the preparation of upadacitinib | |
| HK40062397A (en) | Process and intermediates for the preparation of eldecalcitol | |
| GB201911627D0 (en) | Polymorph of venetoclax and method for preparing the polymorph |